SAM 학술관계분석서비스

논문영향력 요약
주제	drug delivery system hyaluronic acid
147	0	0.0%

논문영향력
주제	주제별 논문수	주제별 피인용횟수	주제별 논문영향력
주제어	drug delivery system	46	0	0.0%
hyaluronic acid	101	0	0.0%
계		147	0	0.0%
* 다른 주제어 보유 논문에서 피인용된 횟수	0

Zipfel, W.R., Williams, R.M., Christie, R., Nikitin, A.Y., Hyman, B.T. and Webb, W.W. Live tissueintrinsic emission microscopy using multiphoton-excited native fluorescence and second harmonicgeneration , Proceedings of the National Academy of Sciences of the United States of America,Vol.100, No.12, 2003, pp.7075-7080.

Zhou, B., Weigel, J.A., Fauss, L.A. and Weigel, P.H. Identification of the hyaluronan receptor forendocytosis , The Journal of biological Chemistry, Vol.275, No.48, 2000, pp.37733-37741.

Zaric, M., Lyubomska, O., Touzelet, O., Poux, C., Al-Zahrani, S., Fay, F., Wallace, L., Terhorst, D.,Malissen, B., Henri, S., Power, U.F., Scott, C.J., Donnelly, R.F. and Kissenpfennig, A. Skin dendriticcell targeting via microneedle arrays laden with antigen-encapsulated poly-D,L-lactide-co-glycolidenanoparticles induces efficient antitumor and antiviral immune responses , ACS Nano, Vol.7, No.3,2013, pp.2042-2055.

Yang, S.Y., O ?Cearbhaill, E.D., Sisk, G.C., Park, K.M., Cho, W.K., Villiger, M., Bouma, B.E.,Pomahac, B. and Karp, J.M. A bio-inspired swellable microneedle adhesive for mechanicalinterlocking with tissue , Nature Communications, Vol.4, 1702.

Yang, J.A., Park, K., Jung, H., Kim, H., Hong, S.W., Yoon, S.K., Hahn, S.K. Target specifichyaluronic acid-interferon alpha conjugate for the treatment of hepatitis C virus infection ,Biomaterials, Vol.32, No.33, 2011, pp.8722-8729.

Yang, J.A., Park, K., Jung, H., Kim, H., Hong, S.W., Yoon, S.K. and Hahn, S.K. Target specifichyaluronic acid-interferon alpha conjugate for the treatment of hepatitis C virus infection ,Biomaterials, Vol.32, No.33, 2011, pp.8722-8729.

Yang, J.A., Kim, E.-S., Kwon, J. H., Kim, H., Shin, J. H., Yun, S. H., Choi, K. Y. and Hahn, S. K. Transdeermal delivery of hyaluronic acid ? Human growth hormone conjugate , Biomaterials, Vol.33,No.59, 2012, pp.5947-5954.

Williams, R.M., Zipfel, W.R. and Webb, W.W. Interpreting second-harmonic generation images ofcollagen I fibrils , Biophysical Journal, Vol.88, No.2, pp.1377-1386.

Wang, Y., Marshall, K.L., Baba, Y., Gerling, G.J. and Lumpkin, E.A. Hyperelastic Material Propertiesof Mouse Skin under Compression , PLoS One, Vol.8, No.6, 2013, e67439.

Wang, B., Zou, Y., Li, H., Yan, H., Pan, J.S. and Yuan, Z.L. Genistein inhibited retinalneovascularization and expression of vascular endothelial growth factor and hypoxia inducible factor1?? in a mouse model of oxygen-induced retinopathy , Journal of Ocular Pharmacology andTherapeutics, Vol.12, No.2, 2005, pp.107-113.

Villadangos, J.A., Cardoso, M., Steptoe, R.J., van Berkel, D., Pooley, J., Carbone, F.R. and Shortman,K. MHC class II expression is regulated in dendritic cells independently of invariant chaindegradation , Immunity, Vol.14, No.6, 2001, pp.739-749.

Verbaan, F.J., Bal, S.M., van der Berg, D.J., Groenink, W.H.H., Verpoorten, H., Luttge, R. andBouwstra, J.A. Assembled microneedle arrays enhance the transport of compounds varying over alarge range of molecular weight across human dermatomed skin , Vol. 117, No.2, 2007, pp.238-245.

Van Damme, P.V., Oosterhuis-Kafeja, F., Van der Wielen, M., Almagor, Y., Sharon, O. and Levin, Y. Safety and efficacy of a novel microneedle device for dose sparing intradermal influenza vaccinationin healthy adults , Vaccine, Vol.27, No.3, 2008, pp.454-459.

Tsuboi, R. and Rifkin, D.B. Recombinant basic fibroblast growth factor stimulates wound healing inhealing-impaired db/ db mice , Journal of Experimental Medicine, Vol.172, No.1, 1990, pp.245-251.

Torchilin, V.P. Recent advances with liposomes as pharmaceutical carriers , Nature Reviews DrugDiscovery, Vol.4, No.2, 2005, pp.145-160.111

Torchilin, V.P. Recent advances with liposomes as pharmaceutical carriers , Nature Reviews DrugDiscovery, Vol.4, No.2, 2005, pp.145-160.

Toole, B.P. and Hay, E.D. Cell Biology of Extracellular Matrix , Plenum, New York, 1991.

Termeer, C.C., Hennies, J., Voith, U., Ahrens, T., Weiss, J.M., Prehm, P. and Simon, J.C. Oligosaccharides of hyaluronan are potent activators of dendritic cells , The Journal of Immunology,Vol.165, No.4, 2000, pp.1863-1870.

Termeer, C., Benedix, F., Sleeman, J., Fieber, C., Voith, U., Ahrens, T., Miyake, K., Freudenberg, M.,Galanos, C. and Simon, J.C. Oligosaccharides of hyaluronan activate dendritic cells via toll-likereceptor 4 , Journal of Experimental Medicine, Vol.195, No.1, 2002, pp.99-111.

Tammi, R., Saamanen, A.M., Maibach, H.I. and Tammi, M. Degradation of newly synthesized highmolecular mass hyaluronan in the epidermal and dermal compartments of human skin in organculture , Journal of Investigative Dermatology, Vol.97, No.1, 1991, pp.126-130.

Takae, S., Miyata, K., Oba, M., Ishii, T., Nishiyama, N., Itaka, K., Yamasaki, Y., Koyama, H. andKataoka, K. PEG-detachable polyplex micelles based on disulfide-linked block catiomers asbioresponsive nonviral gene vectors , Journal of the American Chemicao Society, Vol.130, No.18,2008, pp.6001-6009.

Surendrakumar, K., Martyn, G.P., Hodgers, E.C., Jansen, M. and Blair, J.A. Sustained release ofinsulin from sodium hyaluronate based dry powder formulations after pulmonary delivery to beagledogs , Journal of Controlled Release, Vol.91, No.3, 2003, pp.385-394.

Supko, J.G. and Philips, L.R. High-performance liquid chromatographic assay for genistein inbiological fluids , Journal of Chromatography B, Vol.666, No.1, 1995, pp.157-167.

Sullivan, S.P., Koutsonanos, d.G., Del Pilar Martin, M., Lee, J.W., Zarnitsyn, V. Choi, S.O., Murthy,N., Compans, R.W., Skountzou, I. and Prausnitz, M.R. Dissolving polymer microneedle patches forinfluenza vaccination , Nature Medicine, Vol.16, No.8, 2010, pp.915-920.

Sullivan, S.P., Koutsonanos, D.G., Martin, M.d.P., Lee, J.W., Zarnitsyn, V., Choi, S.-O., Murthy, N.,Campans, R.W., Skountzou, I. and Prausnitz, M.R. Dissolving polymer microneedle patches forinfluenza vaccination , Nature Medicine, Vol.16, No.8, 2010, pp.915-921.

Su, X., Kim, B.-S., Kim, S.R., Hammond, P.T. and Irvine, D.J. Layer-by-layer-assembled multilayerfilms for transcutaneous drug and vaccine delivery , ACS Nano, Vol.3, No.11, 2009, pp.3719-3729.

Stern, R., Shuster, S., Neudecker, B.A. and Formby, B. Lactate stimulates fibroblast expression ofhyaluronan and CD44: The Warburg effect revisited , Experimental Cell Research, Vol. 276, No.1,2002, pp. 24-31.

Solchaga, L.A., Dennis, J.E., Goldberg, V.M. and Caplan, A.I. Hyaluronic acid-based polymers ascell carriers for tissue-engineered repair of bone and cartilage , Journal of Orthopaedic Research,Vol.17, No.2, 1999, pp.205-213.

Slutter, B., Soema, P.C., Zing, D., Verheul, R., Hennink, W. and Jiskoot, W. Conjugation ofovalbumin to trimethyl chitosan improves immunogenicity of the antigen , Journal of ControlledRelease, Vol.143, No.2, 2010, pp.207-214.

Skrabalak, S.E., Chen, J., Sun, Y., Lu, X., Au, L., Cobley, C.M. and Xia, Y. Gold nanocages:Synthesis, properties, and aplications , Accounts of Chemical Research, Vol.41, No.12, 2008,pp.1587-1595.

Sen, D., Forrest, L., Kepler, T.B., Parker, I. and Cahalan, M.D. Selective and site-specificmobilization of dermal dendritic cells and Langerhans cells by Th1- and Th2-polarizing adjuvants ,Proceedings of the National Academy of Sciences of the United States of America, Vol.107, No.18,2010, pp.8334-8339.

Scheibner, K.A., Lutz, M.A., Boodoo, S., Fenton, M.J., Powell, J.D. and Horton, M.R. Hyaluronanfragments act as an endogenous danger signal by engaging TLR2 , The Journal of Immunology,Vol.177, No.2, 2006, pp.1272-1281.

Sahoo, S.K. and Labhasetwar, V. Nanotech approaches to drug delivery and imaging , DrugDiscovery Today, Vol.8, No.24, 2003, pp.1112-1120.

Saettone, M.F., Chetoni, P., Torracca, M.T., Burgalassi, S. and Giannaccini, B. Evaluation of mucoadhesiveproperties and in vivo activity of ophthalmic vehicles based on hyaluronic acid ,International Journal of Pharmaceutics, Vol.51, No.3, .1989, pp.203-212.

Qin, S., Geng, Y., Discher, D.E. and Yang, S. Temperature-controlled assembly and release frompolymer vesicles of poly(ethylene oxide)-block-poly(N-isopropylacrylamide) , Advanced Materials,Vol.18, No.21, 2006, pp.2905-2909.

Qhattal, H.S. and Liu, X. Characterization of CD44-mediated cancer cell uptake and intracellulardistribution of hyaluronan-grafted liposomes , Molecular Pharmaceutics, Vol.8, No.4, 2011, pp.1233-1246.

Polat, B.E., Hart, D., Langer, R. and Blankschtein, D. Ultrasound-mediated transdermal drug delivery:Mechanisms, scope, and emerging trends , Journal of Controlled Release, vol.152, No.3, 2011,pp.330-348.

Plotkin,S. A. Vaccines: past, present and future , Nature Medicine, Vol.11, No.4, 2005, pp.S5-S11.

Pissuwan, D., Nose, K., Kurihara, R., Kaneko, K., Tahara, Y., Kamiya, N., Goto, M., Katayama, Y. andNiidome, T. A solid-in-oil dispersion of gold nanorods can enhance transdermal protein delivery andskin vaccination , Small, Vol.7, No.2, 2011, pp.215-220.

Park, J.H., Kim, J.H., Park, K., Kim, K. and Kwon, I.C. Polymeric nanomedicine for cancer therapy ,Progress in Polymer Science, Vol.33, No.1, 2008, pp.113-137.

Park, J.-H., Choi, S.-O., Seo, S., Choy, Y.B. and Prausnitz, M.R. A microneedle roller for transdermaldrug delivery , European Journal of Pharmaceutics and Biopharmaceutics, Vol.76, No.2, 2010,pp.282-289.

Oh, E.J., Park, K., Kim, K.S., Kim, J., Yang, J.A., Kong, J.H., Lee, M.Y., Hoffman, A.S. and Hahn,S.K. Target specific and long-acting delivery of protein, peptide, and nucleotide therapeutics usinghyaluronic acid derivatives , Journal of Controlled Release, Vol.141, No.1, 2010, pp.2-12.

Oh, E.J., Park, K., Choi, J.S., Joo, C.K. and Hahn, S.K. Synthesis, characterization, and preliminaryassessment of anti-Flt1 peptide - hyaluronate conjugate for the treatment of cornealneovascularization , Biomatierlas, Vol.30, No.30, 2009, pp.6026-6034.

Oh, E.J., Kim, J.W., Kong, J.H., Ryu, S.H. and Hahn, S.K. Signal transduction of hyaluronic acid ?peptide conjugate for formyl peptide receptor like 1 receptor , Bioconjugate Chemistry, Vol.19,No.12, 2008, pp.2401-2408.

Oh, E.J., Choi, J.S., Kim, H., Joo, C.K. and Hahn, S.K. Anti-Flt1 peptide ? hyaluronate conjugate forthe treatment of retinal neovascularization and diabetic retinopathy , Biomaterials, Vol.32, No.11,2011, pp.3115-3123.116

Oh, E.J., Choi, J.S., Kim, H., Joo, C.K. and Hahn, S.K. Anti-Flt1 peptide ? hyaluronate conjugate forthe treatment of retinal neovascularization and diabetic retinopathy , Biomaterials, Vol.32, No.11,2011, pp.3115-3123.

Nordquist, L., Roxhed, N., Griss, P. and Stemme, G. Novel microneedle patches for active insulindelivery are efficient in maintaining glycaemic control: An initial comparison with subcutaneous122administration , Pharmaceutical Research, Vol.24, No.7, 2007, pp.1381-1388.

Ng, P.C. The effectiveness and side effects of dexamethasone in preterm infants withbronchopulmonary dysplasia , Archives of Disease in Childhood, Vol.68, No.3, 1993, pp.330-336.

National Heart, Lung, and Blood Institute. Guidelines for the diagnosis and management of asthma(EPR-3) , 2007. Available from URL: http://www.nhlbi.nih.gov/health-pro/guidelines/current/asthmaguidelines,pp.214.

Nasongkla, N., Bey, E., Ren, J., Ai, H., Khemtong, C., Guthi, J.S., Chin, S.F., Sherry, A.D., Boothman,D.A. and Gao, J. Multifunctional polymeric micelles as cancer-targeted, MRI-ultrasensitive drugdelivery systems , Nano Letters, Vol.6, No.11, 2006, pp.2427-2430.

Nanney, L.B. Epidermal and dermal effects of epidermal growth factor during wound repair , Journalof Investigative Dermatology, Vol.94, No.5, 1990, pp.624-629.

Nakanishi, C. and Toi, M.. Nuclear factor-??B inhibitors as sensitizers to anticancer drugs , NatureReviews Cancer, Vol.5, No.4, 2005, pp.297-309.

Muto, J., Morioka, Y., Yamasaki, K., Kim, M., Garcia, A., Carlin, A.F., Varki, A. and Gallo, R.L. Hyaluronan digestion controls DC migration from the skin, Journal of Clinical Investigaton, Vol.124,No.3, 2014, pp.1309-1319.

Moon, J.J., Suh, H., Bershteyn, A., Stephan, M.T., Liu, H., Huang, B., Sohail, M., Luo, S., Um, S.H.,Khant, H., Goodwin, J., Ramos, J., Chiu, W. and Irvine, D.J. Interbilayer-crosslinked multilamellarvesicles as synthetic vaccines for potent humoral and cellular immune responses , Nature Materials,Vol.10, No.3, 2011, pp.243-251, b) Bachmann, M. F. and Jennings, G. T. Vaccine delivery: a matterof size, geometry, kinetics and molecular patterns , Nature Reviews Immunology, Vol.10, No.11, 2010,pp.787-796.

Moghimi, S.M., Hunter, A.C. and Murray, J.C. Long-circulating and target-specific nanoparticles:Theory to practice , Pharmacological Reviews, Vol.53, No.2, 2001, pp.283-318.

McKee, C.M., Penno, M.B., Cowman, M., Burdick, M.D., Strieter, R.M., Bao, C. and Noble, P.W. Hyaluronan (HA) fragments induce chemokine gene expression in alveolar macrophages. The role ofHA size and CD44 , Journal of Clinical Investigation, Vol.98, No.10, 1996, pp.2403-2413.

Liu, Z., Jiao, Y., Wang, Y., Zhou, C. and Zhang, Z. Polysaccharides-based nanoparticles as drugdelivery systems , Advanced Drug Delivery Reviews, Vol.60, No.15, 2008, pp.1650-1662.

Leggatt, G..R., Dunn, L.A., De kluyver, R.L., Stewart, T. and Frazer, I.H. Interferon-gamma enhancescytotoxic T lymphocyte recognition of endogenous peptide in keratinocytes without lowering therequirement for surface peptide , Immunology anc Cell Biology, Vol.80, No.5, 2002, pp.415-424.120

Lee, K.S., Min, K.H., Kim, S.R., Park, S.J., Park, H.S., Jin, G.Y. and Lee, Y.C. Vascular endothelialgrowth factor modulates metalloproteinase-9 expression in asthma , American Journal of Respiratoryand Critical Care Medicine, Vol.174, No.2, 2006, pp.161-170.

Laurent, T.C. and Fraser, R.E. Hyaluronan , The FASEB Journal, Vol.6, No.7, 1992, pp.2397-2404.

Laurent, T.C. and Balazs, E.A. Chemistry and Molecular Biology of the Intercellular Matrix ,Academic Press, London, 1970.

Laurent, T.C. The Chemistry, Biology and Medical Applications of Hyaluronan and Its Derivatives ,Portland Press, London, 1998.

Laato, M., Niinikoski, J., Lebel, L. and Gerdin, B. Stimulation of wound healing by epidermalgrowth factor. A dose-depemdent effect. , Vol.203, No.4, 1986, pp.379-381.

LaVan, D.A., McGuire T. and Langer, R. Small-scale systems for in vivo drug delivery , NatureBiotechnology, Vol.21, No.10, 2003, pp.1184-1191.

Kupper, T.S. and Fuhlbrigge, R.C. Immune surveillance in the skin: mechanisms and clinicalconsequences , Nature Reviews Immunology, Vol.4, No.3, 2004, pp.211-222.

Kuo, J.W. Practical Aspects of Hyaluronan-Based Medical Products , CRC Press, New York, 2006.

Kostarelos, K., Bianco A. and Prato, M. Promises, facts and challenges for carbon nanotubes inimaging and therapeutics , Nature Nanotechnology, Vol.4, 2009, pp.627-633.

Kogan, G., Soltes, L., Stern, R. and Gemeiner, P. Hyaluronic acid: a natural biopolymer with a broadrabnge of biomedical and industrial applications , Biotechnology Letters, Vol.29, No.1, 2009, pp.17-25.

Kinstler, O., Molineux, G., Treuheit, M., Ladd, D. and Gegg, C. Mono-N-terminal poly(ethyleneglycol)-protein conjugates , Advanced Drug Delivery Reviews, Vol.54, No.4, 2002, pp.477-485, b)Tao, L., Mantovani, G., Lecolley, F. and Haddleton, D.M. Alpha-aldehyde terminally functionalmethacrylic polymers from living radical polymerization: application in protein conjugation"pegylation" , Journal of the American Chemicao Society, Vol.126, No.41, 2004, pp.13220-13221.

Kim, Y.S., Hong, S.W., Choi, J.P., Shin, T.S., Moon, H.G., Choi, E.J., Jeon, S.G., Oh, S.Y., Gho, Y.S.,Zhu, Z. and Kim, Y.K. Vascular endothelial growth factor is a key mediator in the development of Tcell priming and its polarization to type 1 and type 17 T helper cells in the airways , The Journal ofImmunology, Vol.183, No.8, 2009, pp.5113-5120.

Kim, Y.S., Choi, S.J., Tae, Y.M., Lee, B.J., Jeon, S.G., Oh, S.Y., Gho, Y.S., Zhu, Z. and Kim, Y.K. Distinct roles of vascular endothelial growth factor receptor-1- and receptor-2-mediated signaling inT cell priming and Th17 polarization to lipopolysaccharide-containing allergens in the lung , TheJournal of Immunology, Vol.185, No.9, 2010, pp.5648-5655.

Kim, Y.K., Oh, S.Y., Jeon, S.G., Park, H.W., Lee, S.Y., Chun, E.Y., Bang, B., Lee, H.S., Oh, M.H.,Kim, Y.S., Kim, J.H., Gho, Y.S., Cho, S.H., Min, K.U., Kim, Y.Y. and Zhu, Z.Z. Airway exposurelevels of lipopolysaccharide determine type 1 versus type 2 experimental asthma , The Journal ofImmunology, Vol.178, No.8, 2007, pp.5375-5382.

Kim, H., Choi, J.S., Kim, K.S., Yang, J.A., Joo, C.K. and Hahn, S.K. Flt1 peptide ? hyaluronateconjugate micelle-like nanoparticles encapsulating genistein for the treatment of ocularneovascularization , Acta Biomaterialia, Vol.8, No.11, 2012, pp.3932-3940.

Kim, E.S., Chang, Y.S., Choi, S.J., Kim, J.K., Yoo, H.S., Ahn, S.Y., Sung, D.K., Kim, S.Y., Park, Y.R.and Park, W.S. Intratracheal transplantation of human umbilical cord blood-derived mesenchymalstem cells attenuates Escherichia coli-induced acute lung injury in mice , Respiratory Research,Vol.12, 2011, 108.

Kim, B.S., Park, S.W. and Hammond, P.T. Hydrogen-bonding layer-by-layer-assembledbiodegradable polymeric micelles as drug delivery vehicles from surfaces , ACS Nano, Vol.2, No.2,2008, pp.386-392.

Kenney, R.T., Frech, S.A., Muenz,L.R., Villar,C.P. and Glenn, G.M. Dose sparing with intradermalinjection of influenza vaccine , The New England Journal of Medicine, Vol.351, No.22, 2004, pp.2295-2301.

Kendall, F.E., Heidelberger, M. and Dawson, M.H. A serologically inactive polysaccharideelaborated by mucoid strains of group A hemolytic streptococcus , The Journal of BiologicalChemistry, Vol. 118, pp.61?69.

Jung, H.S., Kong, W.H., Sung, D.K., Lee, M.-Y., Beack, S.E., Keum, D.H., Kim, K.S., Yun, S.H. andHahn, S.K. Nanographene oxide-hyaluronic acid conjugate for photothermal ablation therapy of skincancer , ACS Nano, Vol.8, No.1, 2014, pp.260-268.

Jeon, S.G., Moon, H.G., Kim, Y.S., Choi, J.P., Shin, T.S., Hong, S.W., Tae, Y.M., Kim, S.H., Zhu, Z.,Gho, Y.S. and Kim, Y.K. 15-lipoxygenase metabolites play an important role in the development of aT-helper type 1 allergic inflammation induced by double-stranded RNA , Clinical and ExperimentalAllergy, Vol.39, No.6, 2009, pp.908-917.

Ishii, Y., Nakae, T., Sakamoto, F., Matsuo, K., Matsuo, K., Quan, Y.-S., Kamiyama, F., Fujita, T.,Yamamoto, A., Nakagawa, S. and Okada, N. A transcutaneous vaccination system using a hydrogelpatch for viral and bacterial infection , Journal of Controlled Release, Vol.131, No.2, 2008, pp.113-120.

Ibrahim, A.S., El-Shishtawy, M.M., Pena, A. Jr. and Liou, G.I. Genistein attenuates retinalinflammation associated with diabetes by targeting of microglial activation , Molecular Vision, Vol.16,2010, pp.2033-2042.

Hudson, D.L., Sleeman, J. and Watt, F.M. CD44 is the major peanut lectin-binding glycoprotein ofhuman epidermal keratinocytes and plays a role in intercellular adhesion , Journal of Cell Science,Vol.108, No. 5, 1995, pp.1959-1970.

Huang, Y., Park, Y.S., Moon, C., David, A.E., Chung, H.S. and Yang, V.C. Synthetic skin-permeableproteins enabling needleless immunization , Angewandte chemie International Edition, Vol.49, No.15,2010, pp.2724-2727.

Holgate, S.T., Lackie, P.M., Davies, D.E., Roche, W.R. and Walls, A.F. The bronchial epithelium asa key regulator of airway inflammation and remodeling in asthma , Clinical and Experimental Allergy,Vol.29, No.s2, 1999, pp.90-95.

Ho, D. Beyond the sparkle: The impact of nanodiamonds as biolabeling and therapeutic agents ,ACS Nano, Vol.3, No.12, 2009, 3825-3829.

Hirao, L.A., Wu, L., Khan, A.S., Satishchandran, A., Draghia-Akli, R. and Weiner, D.B. Intradermal/subcutaneous immunization by electroporation improves plasmid vaccine delivery andpotency in pigs and rhesus macaques , Vaccine, vol.26, No.3, 2008, pp.440-448.

Henri, S., Poulin, L.F., Tamoutounour, S., Ardouin, L., Guilliams, M., de Bovis, B., Devilard, E., Viret,C., Azukizawa, H., Kissenpfennig, A. and Malissen, B. CD207+ CD103+ dermal dendritic cellscross-present keratinocyte-derived antigens irrespective of the presence of Langerhans cells , TheJournal of Experimental Medicine, Vol.207, No.1, 2010, pp.189-206.

Hashimoto, M., Tanaka, H. and Abe, S. Quantitative analysis of bronchial wall vascularity in themedium and small airways of patients with asthma and COPD , Chest, Vol.127, No.3, 2005, pp.965-972.

Hanania, N.A., Chapman, K.R. and Kesten, S. Adverse effects of inhaled corticosteroids , TheAmerican Journal of Medicine, Vol.98, No.2, 1995, pp.196-208.115

Gurny, R., Ibrahim, H., Aebi, A., Buri, P., Wilson, C.G., Washington, N., Edman, P. and Camber, O. Design and evaluation of controlled release systems for the eye , Journal of Controlled Release,Vol.6, No.1, 1987, pp.367-373.

Gurny, R., Ibrahim, H., Aebi, A., Buri, P., Wilson, C.G., Washington, N., Edman, P. and Camber, O. Design and evaluation of controlled release systems for the eye , Journal of Controlled Release,110Vol.6, No.1, 1987, pp.367-373.

Gramzinski, R.A., Millan, C.L.B., Obaldia, N., Hoffman, S.L. and Davis, H.L. Immune response to ahepatitis B DNA vaccine in Aotus monkeys: A comparison of vaccine formulation, route, and methodof administration , Vol.4, No.2, 1998, pp.109-118.

Goldberg, R.L. and Toole, B.P. Hyaluronate inhibition of cell proliferation , Arthritis andRheumatism, Vol.30, No.7, pp. 769-778.

Ghazi, K., Deng-Pichon, U., Warnet, J.-M. and Rat, P. Hyaluronan fragments improve wound healingon in vitro cutaneous model through P2X7 purinoreceptor basal activation: Role of molecular weight ,PLOS One, Vol.7, No.11, 2012, e48351.

Gerecht, S., Burdick, J.A., Ferreira, L.S., Townsend, S.A., Langer, R. and Vunjak-Novakovic, G. Hyaluronic acid hydrogel for controlled self-renewal and differentiation of human embryonic stemcells , Proceedings of the National Academy of Sciences of the United States of America, Vol.104,No.27, 2007, pp.11298-11303.

Gasparini, G., Longo, R., Fanelli, M. and Teicher, B.A. Combination of antiangiogenic therapy withother anticancer therapies: Results, challenges, and open questions , Journal of Clinical Oncology,Vol.23, No.6, 2005, pp.1295-1311.

Gariboldi, S., Palazzo, M., Zanobbio, L., Selleri, S., Sommariva, M., Sfondrini, L, Cavicchini, S.,Balsari, A. and Rumio, C. Low molecular weight hyaluronic acid increases the self-defense of skinepithelium by induction of ??-defensin 2 via TLR2 and TLR4 , Vol.181, No.3, 2008, pp.2103-2110.

Gadgeel, S.M., Ali, S., Philip, P.A., Wozniak, A. and Sarkar, F.H. Genistein enhances the effect ofepidermal growth factor receptor tyrosine kinase inhibitors and inhibits nuclear factor kappa B innonsmall cell lung cancer cell lines , Cancer, vol.115, No.10, 2009, pp.2165-2176.112

Fuster, M.M. and Esko, J.D. The sweet and sour of cancer: Glycans as novel therapeutic targets ,Nature Reviews Cancer, Vol.5, No.7, pp.526-542.

Friedman, P.M., Mafong, E.A., Kauvar, A.N.B. and Geronemus, R.G. Safety data of injectablenonanimal stabilized hyaluronic acid gel for soft tissue augmentation , Dermatological Surgery, Vol.28,No.6, 2002, pp.491-494.

Fotsis, T., Pepper, M., Adlercreutz, H., Fleischmann, G., Hase, T., Montesano, R. and Schweigerer, L. Genistein, a dietary-derived inhibitor of in vitro angiogenesis , Proceedings of the National Academyof Sciences of the United States of America, Vol.90, No.7, 1993, pp.2690-2694.

Fan, H., Lin, Q., Morrissey, G.R. and Khavari, P.A. Immunization via hair follicles by topical118application of naked DNA to normal skin , Nature Biotechnology, Vol.17, No.9, 1999, pp.870-872.

Etrych, T., Jelinkova, M., Rihova, B. and Ulbrich, K. New HPMA copolymers containingdoxorubicin bound via pH-sensitive linkage: Synthesis and preliminary in vitro and in vivo biologicalproperties , Journal of Controlled Release, Vol.73, No.1, 2001, pp.89-102.

Eiser, E., Miles, C.S., Geerts, N., Verschuren, P. and MacPhee, C.E. Molecular cooking: physicaltransformations in Chinese century ? eggs , Soft Matter, Vol.5, No.14, 2009, pp.2725-2730.

Duncan, R. The drawning era of polymer therapeutics , Nature Reviews Drug Discovery, Vol.2, No.5,2003, pp.347-360.

Duncan, R. Polymer conjugates as anticancer nanomedicines , Nature Reviews Cancer, Vol.6, No.9,2006, pp.688-701.

Doshi, N., Zahr, A.S., Bhaskar, S., Lahann, J. and Mitragotri, S. Red blood cell-mimicking syntheticbiomaterial particles , Proceedings of the National Academy of Sciences of the United States ofAmerica, Vol.106, No.51, 2009, pp.21495-21499.

Do, Y., Nagarkatti, P.S., Nagarkatti, M. Role of CD44 and hyaluronic acid (HA) in activation ofalloreactive and antigen-specific T cells by bone marrow-derived dendritic cells , Journal ofImmunotherapy, Vol.27, No.1, 2004, pp.1-12.

DeMuth, P.C., Min, Y., Huang, B., Kramer, J.A., Miller, A.D., Barouch, D.H., Hammond, P.T. andIrvine, D.J. Polymer multilayer tattooing for enhanced DNA vaccination , Nature Materials, Vol.12,No.4, 2013, pp.367-376, b) Bachy, V., Hervouet, C., Becker, P.D., Chorro, L., Carlin, L.M., Herath, S.,Papagatsias, T., Barbaroux, J.B., Oh, S.J., Benlahrech, A., Athanasopoulos, T., Dickson, G., Patterson,S., Kwon, S.Y., Geissmann, F. and Klavinskis, L.S. Langerin negative dendritic cells promote potentCD8+ T-cell priming by skin delivery of live adenovirus vaccine microneedle arrays , Proceedings ofthe National Academy of Sciences of the United States of America. Vol.110, No.8, 2013, pp.3041-3046.

Davila, E. and Celis, E. Repeated administration of cytosine-phosphorothiolated guanine-containingoligonucleotides together with peptide/protein immunization results in enhanced CTL responses withanti-tumor activity , The Journal of Immunology, Vol.165, No.1, 2000, pp.539-547.123

Comper W.D. and Laurent, T.C. Physiological function of connective tissue polysaccharides ,Physiological Reviews, Vol.58, No.1, 1978, 255-315.

Cohn, L., Elias, J.A. and Chupp, G.L. Asthma: mechanisms of disease persistence and progression ,Annual Reviews of Immunology Vol.22, 2004, 789-815.

Choi, M. and Yun, S.H. In vivo femtosecond endosurgery: an intestinal epithelial regeneration-afterinjurymodel , Optical Express, Vol.21, No.25, 2013, pp.30842-30848.

Choi, J.S., Leong, K.W. and Yoo, H.S. In vivo wound healing of diabetic ulcers using electrospunnanofibers immobilized with human epidermal growth factor (EGF) , Biomaterials, Vol.29, No.5,2008, pp.587-596.

Cho, S.H., Stanciu, L.A., Holgate, S.T. and Johnston, S.L. Increased interleukin-4, interleukin-5, andinterferon-gamma in airway CD4+ and CD8+ T cells in atopic asthma , American Journal ofRespiratory and Critical Care Medicine, Vol.171, No.3, 2005, pp.224-230.

Chetta, A., Zanini, A., Foresi, A., Del Donno, M., Castagnaro, A, D ?lppolito, R., Baraldo, S., Testi, R.,Saetta, M. and Olivieri, D. Vascular component of airway remodeling in asthma is reduced by highdose of fluticasone , American Journal of Respiratory and Critical Care Medicine, Vol.167, No.5,2003, pp.751-757.114

Chetta, A., Zanini, A., Foresi, A., D ?lppolito, R., Tipa, A., Castagnaro, A., Baraldo, S., Neri, M.,Saetta, M. and Olivieri, D. Vascular endothelial growth factor up-regulation and bronchial wallremodeling in asthma , Clinical and Experimental Allergy, Vol.35, No.11, 2005, pp.1437-1442.

Chen, X., Shah, D., Kositratna, G., Manstein, D., Anderson, R.R. and Wu, M.X. Facilitation oftranscutaneous drug delivery and vaccine immunization by a safe laser technology , Journal ofControlled Release, Vol.159, No.1, 2012, pp.43-51.

Chen, D., Endres, R.L., Erickson, C.A., Weis, K.F., McGregor, M.W., Kawaoka, Y. and Payne, L.G. Epidermal immunization by a needle-free powder delivery technology: immunogenicity of influenza117vaccine and protection in mice , Nature Medicine, Vol.6, No.10, 2000, pp.1187-1190.

Busse, W.W. and Lemanske, R.F. Jr. Asthma , The New England Journal of Medicine, Vol.344,No.5, 2001, pp.350-362.

Burger, K., Illes, J., Gyurcsik, B., Gazdag, M., Forrai, E., Dekany, I. and Mihalyfi, K. Metal ioncoordination of macromolecular bioligands: formation of zinc(II) complex of hyaluronic acid ,Carbohydrate Research, Vol.332, No.2, 2001, pp.197-207.

Burda, C., Chen, X., Narayanan, R. and El-Sayed, M.A., Chemistry and properties of nanocrystals ofdifferent shapes , Chemical Reviews, Vol.105, No.4, 2005, pp.1025-1102.

Bullens, D.M., Truyen, E., Coteur, L., Dilissen, E., Hellings, P.W., Dupont, L.J. and Ceuppens, J.L. IL-17 mRNA in sputum of asthmatic patients: linking T cell driven inflammation and granulocyticinflux? , Respiratory Research, Vol.7, No.1, 2006, pp.135-139.

Buckley, A., Davidson, J.M., Kamerath, C.D., Wolt, T.B. and Woodward, S.C., Sustained release ofepidermal groth factor accelerates wound repair , Proceedings of the National Academy of Sciences ofthe United States of America, Vol.82, No.21, 1985, pp.7340-7344.

Bryan, C.P., Alison, L.B., Alan, P.B., Matthew, A.S. and Nicholas, W.L. Interleukin-25 induces type2 cytokine production in a steroid-resistant interleukin-17RB+ myeloid population that exacerbatesasthmatic pathology , Nature Medicine, Vol.18, No.5, 2012, pp.751-758.

Brown, T.J., Alcorn, D. and Fraser, J.R. Absorption of hyaluronan applied to the surface of intactskin , Journal of Investigative Dermatology, Vol.113, No.5, 1999, pp.740-746.

Brown, M.B. and Jones, S.A. Hyaluronic acid: a unique topical vehicle for the localized delivery ofdrugs to the skin , Journal of the European Academy of Dermatology and Venereology, Vol.19, No.3,2005, pp.308-318.

Brown, G.L., Curtsinger, L. III, Brightwell, J.R., Ackerman, D.M., Tobin, G.R., Polk, H.C. Jr.,121George-Nascimento, C., Valenzuela, P. and Schultz, G.S. Enhancement of epidermal regeneration bybiosynthetic epidermal growth factor , Brief Definitive Report, Vol.163, No.5, 1986, pp.1319-1324.

Breeuwer, P., Drocourt, J., Rombouts, F.M. and Abee, T. A novel method for continuousdetermination of the intracellular pH in bacteria with the internally conjugated fluorescent probe 5(and 6-)-carboxyfluorescein succinimidyl ester , Applied and Environmental Microbiology, Vol.62,No.1, 1996, pp.178-183.

Brecht, M., Mayer, U., Schlosser E. and Prehm, P. Increased hyaluronate synthesis is required forfibroblast detachment and mitosis , Biochemical Journal, Vol.239, No.2, pp.445-450.

Braiman-Wiksman, L., Solomonik, I., Spira, R. and Tennebaum, T. Novel insights into woundhealing sequence of events , Toxicologic Pathology, Vol.35, No.6, 2007, pp.767-779.

Boes, M., Cerny, J., Massol, R., Op den Brouw, M., Kirchhausen, T., Chen, J. and Ploegh, H.L. T-cell119engagement of dendritic cells rapidly rearranges MHC class II transport , Nature, Vol.418, No.6901,2002, pp.983-988.

Bochner, B.S., Undem, B.J. and Lichtenstein, L.M. Immunological aspects of allergic asthma ,Annual Reviews of Immunology, Vol.12, 1994, pp.295-335.113

Boas, N.F. Isolation of hyaluronic acid from the cock ?s comb , The Journal of Biological Chemistry,Vol.181, No.2, 1949, pp.573?575.

Bertrand, N. and Leroux, J.C. The journe of a drug-carrier in the body: An anatomo-physiologicalperspective , Journal of Controlled Release, vol.161, No.2, 2012, pp.152-163.

Benedetti, L., Cortivo, R., Berti, T., Pea, F., Mazzo, M., Moras, M. and Abatangelo, G. Biocompatibility and biodegradation of different hyaluronan derivatives (Hyaff) implanted in rats ,Biomaterials, Vol.14, No.15, 1993, 1154-1160.109

Bedoui, S., Whitney, P.G., Waithman, J., Eidsmo, L., Wakim, L., Caminschi, I., Allan, R.S., Wojtasiak,M., Shortman, K., Carbone, F.R., Brooks, A.G. and Heath, W.R. Cross-presentation of viral and selfantigens by skin-derived CD103+ dendritic cells , Nature Immunology, Vol.10, No.5, 2009, pp.488-495.

Banerji, S., Ni, J., Wang, S.X., Clasper, S., Su, J., Tammi, R., Jones, M. and Jackson, D.G. LYVE-1,a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan , The Journalof Cell Biology, Vol.144, No.4, 1999, pp.789-801.

Baldwin, S.L., Bertholet, S., Kahn, M., Zharkikh, I., Ireton, G.C., Vedvick, T.S., Reed, S.G. and Coler,R.N. Intradermal immunization improves protective efficacy of a novel TB vaccine candidate ,Vaccine, Vol.27, No.23, 2009, pp.3063-3071.

Bae, D.G., Kim, T.D., Li, G., Yoon, W.H. and Chae, C.B. Anti-Flt1 peptide, a vascular endothelialgrowth factor receptor 1-specific hexapeptide, inhibits tumor growth and metastasis , ClinicalCancer Research, Vol.11, No.7, 2005, pp.2651-2661.

Alpar, H.O., Somavarapu, S., Atuah, K.N. and Bramwell, V.W. Biodegradable mucoadhesiveparticulates for nasal and pulmonary antigen and DNA delivery , Advanced Drug Delivery Reviews,vol.57, No.3, 2005, pp.411-430.

Allen, T.M. and Cullis, P.R. Drug delivery systems: Entering the mainstream , Vol.303, No.5665,2004, pp.1818-1822.

Al-Qadi, S., Grenha, A. and Remunan-Lopez C. Microspheres loaded with polysaccharidenanoparticles for pulmonary delivery: Preparation, structure and surface analysis , CarbohydratePolymers, vol.86, No.1, 2011, pp.25-34.

Aggarwal, B.B. and Shishodia, S. Molecular targets of dietary agents for prevention and therapy ofcancer , Biochemical Pharmacology, Vol.71, No.10, 2006, pp.1397-1421.

Hyaluronic Acid Derivatives for Smart Drug Delivery Systems : 생체고분자 히알루론산을 이용한 지능형 약물 전달 시스템

유사주제 논문( 145)

' Hyaluronic Acid Derivatives for Smart Drug Delivery Systems : 생체고분자 히알루론산을 이용한 지능형 약물 전달 시스템' 의 주제별 논문영향력

주제별 논문영향력

' Hyaluronic Acid Derivatives for Smart Drug Delivery Systems : 생체고분자 히알루론산을 이용한 지능형 약물 전달 시스템' 의 참고문헌

' Hyaluronic Acid Derivatives for Smart Drug Delivery Systems : 생체고분자 히알루론산을 이용한 지능형 약물 전달 시스템' 의 유사주제( ) 논문